Tweets that tell a story: a new approach to boosting HPV vaccination
NCT ID NCT05204030
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial investigates whether narrative (story-based) messages on Twitter are more effective than factual messages at encouraging parents to vaccinate their children against HPV. Parents of children aged 9–14 who have not started the HPV vaccine series will be randomly assigned to see either storytelling or fact-based tweets. The study measures whether the messages increase empathy, engagement, and ultimately, vaccination rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HPV Twitter Education Program - Narrative and Non-Narrative messages
- What this could lead to
- If storytelling on social media proves more effective, it could offer a low-cost way to boost HPV vaccination rates and reduce vaccine-preventable cancers.
- What could go wrong
- This is a small, early-stage trial with only 28 participants, so results may not apply broadly. Social media engagement does not always translate into actual vaccination.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Arkansas
Fayetteville, Arkansas, 72701, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine shield transplant patients from shingles?
- Can the HPV vaccine fully protect transgender women and people with HIV?
- Could HPV shots start earlier? study tests vaccine in kids as young as 4
- Immune cell therapy takes on HPV
- ERs may soon offer At-Home HPV tests to reach women who skip screenings
- Which COVID-19 shot causes fewer side effects? new study compares novavax and pfizer